This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Williamson, I. Articles by Crompton, G. Search for Related Content PubMed PubMed Citation Articles by Williamson, I. Articles by Crompton, G.

Original Articles

Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations

The aim of the study was to assess the prevalence of throat and voice symptoms in asthma patients using pressurized aerosol, metered-dose, inhaled corticosteroid preparations. A questionnaire was administered to hospital out-patients in an asthma clinic and to a control group attending a diabetic clinic. Two hundred and fifty five consecutive out-patients using pressurized aerosol inhaled corticosteroids and 100 controls were surveyed. One hundred and forty seven (58%) patients taking inhaled steroids reported voice dysphonia or throat symptoms compared with 13% of control patients. Women admitted to symptoms more frequently than men. Throat symptoms were more prevalent in patients using higher doses of inhaled steroid. Aerosol inhaler-induced cough was reported by 87 (34%) patients. Local side-effects were equally prevalent both with beclomethasone dipropionate and budesonide aerosol inhalers. The use of a large volume spacing device with either steroid aerosol did not appear to protect against these symptoms. Local side-effects are common in asthmatics taking pressurized aerosol, metered-dose, inhaled steroids.

This article has been cited by other articles:

				E. Erickson and M. Sivasankar Evidence for Adverse Phonatory Change Following an Inhaled Combination Treatment J Speech Lang Hear Res, February 1, 2010; 53(1): 75 - 83. [Abstract] [Full Text] [PDF]

				L. Cicutto Review: inhaled corticosteroids increase risk of oral candidiasis, dysphonia, and pharyngitis in persistent asthma Evid. Based Nurs., October 1, 2007; 10(4): 109 - 109. [Full Text] [PDF]

				H. Derendorf, R. Nave, A. Drollmann, F. Cerasoli, and W. Wurst Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur. Respir. J., November 1, 2006; 28(5): 1042 - 1050. [Abstract] [Full Text] [PDF]

				R. S. Irwin and N. D. Richardson Side Effects With Inhaled Corticosteroids: The Physician's Perception Chest, July 1, 2006; 130(1_suppl): 41S - 53S. [Abstract] [Full Text] [PDF]

				K. Richter, F. Kanniess, C. Biberger, R. Nave, and H. Magnussen Comparison of the Oropharyngeal Deposition of Inhaled Ciclesonide and Fluticasone Propionate in Patients With Asthma J. Clin. Pharmacol., February 1, 2005; 45(2): 146 - 152. [Abstract] [Full Text] [PDF]

				N. J. Roland, R. K. Bhalla, and J. Earis The Local Side Effects of Inhaled Corticosteroids: Current Understanding and Review of the Literature Chest, July 1, 2004; 126(1): 213 - 219. [Abstract] [Full Text] [PDF]

				R H Green, C E Brightling, I D Pavord, and A J Wardlaw Management of asthma in adults: current therapy and future directions Postgrad. Med. J., May 1, 2003; 79(931): 259 - 267. [Abstract] [Full Text] [PDF]

				J. M. DelGaudio Steroid Inhaler Laryngitis: Dysphonia Caused by Inhaled Fluticasone Therapy Arch Otolaryngol Head Neck Surg, June 1, 2002; 128(6): 677 - 681. [Abstract] [Full Text] [PDF]

				P. J. BARNES, S. PEDERSEN, and W. W. BUSSE Efficacy and Safety of Inhaled Corticosteroids . New Developments Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53. [Full Text] [PDF]